Effects of a Weight Based Training Program on MS Patients
1 other identifier
interventional
25
1 country
1
Brief Summary
Low bone density is a health risk in older adults and especially people with multiple sclerosis (MS) due to steroid treatments and less mobility. Bone density is a measurement of how dense or strong bones are. Weight-based training may be one method in strengthening bones and providing a beneficial treatment for MS patient rehabilitation. Weight based training involves performing exercises without the use of actual weights, and instead with one's own bodyweight. This study aims to look at the effects of weight-based training on bone density, cognition (ability to learn and understand), and other quality of life issues (i.e. depression) in MS patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable multiple-sclerosis
Started Jul 2019
Shorter than P25 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2019
CompletedFirst Posted
Study publicly available on registry
June 28, 2019
CompletedStudy Start
First participant enrolled
July 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedAugust 15, 2019
August 1, 2019
4 months
June 14, 2019
August 13, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Osteopenia
Change in bone density due to the addition of two body weight training sessions per week for a six (to eight) week time period. Bone density will be measured via a DEXA bone density scan at day one of the trial and a secondary DEXA scan taking place eight weeks after the final training session. The duration of this aspect of the study falls between 14 and 16 weeks depending on participant training schedule and if rescheduled or make up training sessions are needed.
14 to 16 weeks
Secondary Outcomes (2)
Depression and Quality of Life: MSIS (Multiple Sclerosis impact scale) survey/questionnaire
14 to 16 weeks
Cognition
14 to 16 weeks
Study Arms (1)
Addition of bodyweight training
EXPERIMENTALAll participants in this study fall into this non randomized single group. These participants will complete a total of 12 bodyweight training sessions over a six to eight week time period. Participants will attend one session per week at Holy Name Medical Center's Physical Therapy Center and will train for one session at their home or chosen location with the aid of a video guide.
Interventions
Video guided and physical therapist guided bodyweight training sessions will be performed twice a week for 6 (to 8) weeks. These sessions include the following five workouts at 3 sets of 10 repetitions: step ups, calf raises, wall push ups, chair squats, and chair dips.
Eligibility Criteria
You may qualify if:
- Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information (PHI) in accordance with national and local subject privacy regulations.
- Diagnosis of RRMS, PPMS, SPMS, or CIS per the 2010 McDonald's criteria \[Polman 2011\].
- Baseline EDSS score less than 5.5
You may not qualify if:
- Unable or unwilling to provide informed consent.
- Inability to read or understand English.
- Any contraindication to perform weight-based training exercises.
- Use of any supplemental human growth hormone, performance enhancing drug, or anabolic (non-clinical) steroid.
- Participant has become or intends on becoming pregnant.
- Participant has had a relapse in the past 6 months.
- Patients who currently exercise more than three times per week.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Holy Name Medical Center, Inc.lead
- Biogencollaborator
Study Sites (1)
Holy Name Medical Center
Teaneck, New Jersey, 07666, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Ann Picone
Holy Name Medical Center Multiple Sclerosis Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Director of Holy Name Comprehensive Care Center
Study Record Dates
First Submitted
June 14, 2019
First Posted
June 28, 2019
Study Start
July 1, 2019
Primary Completion
November 1, 2019
Study Completion
December 1, 2019
Last Updated
August 15, 2019
Record last verified: 2019-08